Detalhe da pesquisa
1.
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 391(10121): 668-678, 2018 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29249276
2.
Combining viral genomics and clinical data to assess risk factors for severe COVID-19 (mortality, ICU admission, or intubation) amongst hospital patients in a large acute UK NHS hospital Trust.
PLoS One
; 18(3): e0283447, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952555
3.
Multiple pathways of SARS-CoV-2 nosocomial transmission uncovered by integrated genomic and epidemiological analyses during the second wave of the COVID-19 pandemic in the UK.
Front Cell Infect Microbiol
; 12: 1066390, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36741977
4.
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Health Technol Assess
; 22(59): 1-148, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30382016
5.
Haemagglutinin and neuraminidase sequencing delineate nosocomial influenza outbreaks with accuracy equivalent to whole genome sequencing.
J Infect
; 74(4): 377-384, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28104386
6.
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
Trials
; 13: 241, 2012 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23249501